Hyperglycemia and mortality among patients with coronary artery disease

Ding Ding1, Jian Qiu, Xinrui Li

  • 1Corresponding authors: Wenhua Ling, lingwh@mail.sysu.edu.cn.

Diabetes Care
|October 4, 2013
PubMed

Insights

Coronary artery disease (CAD) patients with impaired glucose regulation (IGR) or diabetes face a higher risk of death. Early identification and management of glucose abnormalities are crucial for improving outcomes in CAD patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Known diabetes is a significant risk factor for mortality in patients with coronary artery disease (CAD).
  • The association between other glucose abnormalities and mortality risk in CAD patients remains unclear.
  • Understanding these associations is vital for comprehensive patient management and risk stratification.

Purpose of the Study:

  • To investigate the relationship between various glucose states and the risk of all-cause and cardiovascular disease (CVD) mortality in CAD patients.
  • To determine if glucose abnormalities beyond known diabetes increase mortality risk.

Main Methods:

  • A cohort of 1,726 CAD patients aged 40-85 years was analyzed.
  • Cox proportional hazards regression models were employed to assess the association between baseline glucose status and mortality risk.
  • Multivariable adjustments were made for numerous clinical and demographic factors.

Main Results:

  • Over a median follow-up of 3.1 years, 129 deaths occurred, with 109 from CVD.
  • Impaired glucose regulation (IGR), newly diagnosed diabetes, and known diabetes were associated with significantly increased all-cause and CVD mortality.
  • Specifically, hazard ratios for CVD mortality were 1.89 for IGR, 2.74 for newly diagnosed diabetes, and 2.73 for known diabetes compared to normoglycemia.

Conclusions:

  • CAD patients with IGR, newly diagnosed diabetes, or known diabetes exhibit an elevated risk of cardiovascular disease mortality.
  • These findings underscore the importance of monitoring and managing glucose levels in all CAD patients, not just those with diagnosed diabetes.
Abstract

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...